Treatment and Prognosis of Neurogenic Orthostatic Hypotension : A Prospective Randomized Study

NCT02308124 Phase 4 COMPLETED Results posted

Compare the effect of treatment of midodrine and pyridostigmine in neurogenic orthostatic hypotension and investigate the quality of life of treatment of neurogenic orthostatic hypotension.

Details

Lead sponsor	Seoul National University Hospital
Phase	Phase 4
Status	COMPLETED
Enrolment	87
Start date	2014-11
Completion	2016-09

Conditions

• Orthostatic; Hypotension, Neurogenic

Interventions

• Midodrine
• Pyridostigmine Bromide
• Midodrine + pyridostigmine

Primary outcomes

• Change in Orthostatic BP Drop — after 3-month medical treatment
  Change of orthostatic SBP and DBP drop after 3-month medical treatment compared to initial results.

Countries

South Korea